7 min listen
Final US presidential debate, FDA approves remdesivir, Intel data hit by pandemic
FromFT News Briefing
Final US presidential debate, FDA approves remdesivir, Intel data hit by pandemic
FromFT News Briefing
ratings:
Length:
11 minutes
Released:
Oct 23, 2020
Format:
Podcast episode
Description
Donald Trump and his Democratic challenger, Joe Biden, clashed over issues from the pandemic to foreign policy in their final presidential election debate. Then, the FT’s Demetri Sevastopulo will explain why local races in Texas and around the US could dictate the political make-up of the country for years to come. Plus, Gilead has received the first US regulatory approval for a Covid-19 drug, and Intel reported a decline in data centre revenues and said its earnings fell by nearly a quarter from a year ago due to the pandemic.Donald Trump and Joe Biden clash over coronavirus in final debatehttps://www.ft.com/content/bef48683-9bde-4ac2-8906-797779593b22Gilead secures FDA approval for remdesivir https://www.ft.com/content/07a321de-109b-46aa-99bc-f884e0ed7703 See acast.com/privacy for privacy and opt-out information.
Released:
Oct 23, 2020
Format:
Podcast episode
Titles in the series (100)
Friday, October 19: Tougher talk from the US on Saudi Arabia, Uber’s move from drivers to waiters and why Wall Street traded lower on Thursday. Plus, a report from day two of the EU summit. by FT News Briefing